Please use this identifier to cite or link to this item: https://ah.lib.nccu.edu.tw/handle/140.119/124899
題名: 醫療法律糾紛之解決途徑研析 - 以大腸直腸肛門科為核心
Critical analysis of the solutions to medical malpractice claims – from a colorectoanal surgeon`s point of view
作者: 林天立
Lin, Tien-Li
貢獻者: 王文杰
Wang, Wen-Chieh
林天立
Lin, Tien-Li
關鍵詞: 醫療糾紛
醫療事故
大腸直腸肛門科
Medical dispute
Medical malpractice
Colorectal Surgery Division
日期: 2019
上傳時間: 7-Aug-2019
摘要: 醫療糾紛,是醫者最沉痛的試煉。時代變遷,病患權利意識逐漸抬頭,醫療環境已發生前所未有的改變。本論文以一位大腸直腸肛門科醫師,剖析親身經歷血淚交織的醫療糾紛個案,統整出相關法律議題,從涉及實務操作面向之醫療行為同意書的簽署、診斷書之開立、醫療鑑定之運作;制度層面的醫療事故預防與補償機制、非訟調處等,做深度探討。本文貴於真實,旨在提出解決方案。\n本研究結論:醫療糾紛的解決對策,須從醫糾的根源,醫療不良事件發生的預防,以免責為基礎、完善的病人安全制度做起;而和諧的醫病關係與良好的溝通技巧、善盡說明義務及鼓勵尋求第二意見、跨領域團隊合作照護及醫病共享決策,來防止爭議的產生;一旦從爭議轉變成糾紛,專業的醫療事故關懷處理團隊、善用有調解前「初步鑑定」程序的醫療糾紛非訴訟調處機制、社會救助及社會保險制度的適時介入、醫療專業責任保險與互助會適度移轉風險、為傷害止血;而法律制度面,秉持「醫療事故即時關懷」、「醫療爭議調解先行」、「預防除錯提升品質」三大原則的「醫療事故預防及爭議處理法」;以界定明確的醫療事故項目制定「大腸鏡醫療事故救濟條例」;醫院為醫師投保醫師業務責任保險,及醫事人員強制責任保險,應立法予以保障。\n由於醫療糾紛的特殊性,法庭不是醫病雙方最好的對話空間,進入訴訟程序,只是掉入另一個泥沼,對彼此都是傷害的延伸。讓醫師在醫院努力對抗疾病,不用浪費時間到法庭來打訴訟;讓病人在醫院接受最完整的治療,而不是奔波在法院重提舊傷口,才是最好的結果。
Medical malpractices are the bitterest ordeals for doctors. As times change, the awareness of patients’ rights had gradually risen, and the medical environment has undergone unprecedented changes. In this paper, the author analyzed cases of medical disputes that he himself has experienced as a colorectoanal surgeon, and integrated,relevant legal issues from the signing of medical consent, issuing the certificate of diagnosis and the operations of medical assessment, to the prevention and compensation mechanism of medical malpractices at the institutional level as well as non-litigation mediation for an in-depth discussion. The article is valued for its authenticity and genuineness and aims to propose viable solutions.\nThe conclusion of this study is that the solutions to medical disputes should start with the prevention of the cause of medical malpractice claim, and the improvement of patient safety system based on exemption. Harmonious doctor-patient relationship, good communication skills, elaboration of obligations, encouragement to seek a second opinion, cross-disciplinary teamwork, health care as well as shared decision making can all help to prevent disputes from arising. Once a controversy turns into disputes, the professional medical malpractice care team should be established, and it should make good use of non-litigation mediation mechanism with pre-mediation “preliminary appraisal” procedure. There should be also the timely and proper intervention of social assistance and social insurance system. Medical professional liability insurance and mutual assistance should also intervene appropriately to stop the situation from further deteriorating. In terms of the legal system, the “medical malpractice prevention and dispute resolution act” with the three principles of “immediate care for medical malpractice”, “preliminary mediation of medical dispute” and “prevention and removal of errors for quality improvement” should be adhered. To define clearly the medical malpractice items, the “regulations on the relief of colonoscopy medical malpractice” should be established. It should be guaranteed by legislation that hospitals should take out an insurance policy for medical professional liability insurance and compulsory liability insurance for medical personnel.\nFor the particularity of medical malpractices, courts are not the best place for dialogue between doctors and patients. Entering the litigation process is just falling into another quagmire, and is simply an extension of the harm to each other. It is best to let doctors fight diseases in the hospital instead of wasting time in court. Allowing the patient to receive the most complete treatment in the hospital without rushing to the court to reopen the wounds is the best outcome.
參考文獻: 一、中文參考文獻\n(一)專書\n1.王澤鑑,侵權行為法:基本理論之一般侵權行為,頁296,2003年10月,自版。\n2.吳正吉,護理人員如何預防與解決醫療糾紛,醫事法學,頁74-77,1996年。\n3.林誠二,民法債編總論(上),自版,頁240- 241,2000年9月。\n4.林鈺雄,新刑法總則,163-172頁,2014年。\n5.施茂林,醫病關係與法律風險管理防範,五南圖書出版公司,頁227,2015年10月。\n6.陳學德,美國道歉制度的沿革及啟示,元照出版,初版,頁38,2014 年6 月。\n7.鄭逸哲,臨床裁量權v.s.醫療常規,頁12-13,2014年。\n8.鄭燦堂,風險管理,理論與實務,頁19至20 ,2016年八版。\n9.鄭玉波,民法債編總則,三民,頁161-162,1990年9月。\n10.醫療爭議處理參考手冊第四版。\n(二)期刊論文\n1.台大法學論叢第33卷第4期,頁46,2007年2月。\n2.台灣本土法學雜誌第39期,頁106,2002年10月。\n3.何盈青,醫療訴訟起訴前之紛爭解決機制,以台中地方法院醫療試辦制度為例,國立政治大學法律系碩士論文,2018年。\n4.吳若儒,我國醫療糾紛處理及醫療事故補償法發展之光與影,國立政治大學法學院碩士在職專班碩士論文,2018年。\n5.林杏麟、李維哲,醫療刑法與巨額賠償引發之防禦性醫療-壓死健保的最後一根稻草,臺灣醫界,第53 卷第12 期,頁636-638,2010 年12 月。\n6.邱琦,臺日民事醫療訴訟—實務比較研究(下),月旦醫事法報告,第3 期,頁159,2017 年1 月。\n7.洪敏瑜,<醫學研究中告知後同意之法律意涵>,國立清華大學科技法律研究所論文,2009年。\n8.高添富、高銘佑,自「生育事故爭議事件試辦計畫」探討「醫療糾紛處理及醫療事故補償法」之立法走向─醫界觀點,醫事法學,第21 期第2 卷 ,頁21-34,2014 年12 月。\n9.高添富,醫療糾紛去刑事訴訟化才是今後修法重點。第55 卷第10 期,頁41-44,2012 年10 月。\n10.陳學德,美國道歉制度的沿革及啟示,元照出版,頁38,2014 年6 月初版。\n11.陳君傑,醫療糾紛處理之法制研究。國立高雄大學法律系研究所碩士論文,2018年。\n12.曾建元,病人權利的倫理難題兼論醫療倫理委員會與倫理諮詢專員在其間的角色,應用倫理研究通訊,25期,頁31-32, 2003年。\n13.張家維、楊智傑,美國醫療糾紛揭露制度之研究-以美國醫療錯誤揭露與賠償法案為中心,治未指錄:健康政策與法律論叢,第3 期,頁147, 2015 年1 月。\n14.張嘉訓、吳佳琳,簡述「醫療糾紛處理及醫療事故補償法」草案,臺灣醫界,第56 卷第3 期,頁8-12,2013 年3 月。\n15.張孟源、張嘉訓、吳佳琳,解決醫療糾紛的拼裝車─談「調解制度」與「補償制度」。台灣醫界,第56 卷第4 期,頁10-14,2013 年4 月。\n16.葛謹,英國醫療糾紛處理制度:對改進我國制度之啟示,臺灣醫界,第51 卷第2 期,頁41,2008 年2 月。\n17.楊秀儀,從無過失重回過失--紐西蘭有關醫療傷害補償制度之變遷及對台灣之啟示,政大法學評論,64期,頁97-119, 2000年。\n18.楊秀儀,美國告知後同意法則之考察分析,月旦法學雜誌,121期,頁141, 2005年。\n19.鄭逸哲,臨床裁量權和行為有價值乃醫療民法和醫療刑法不可抵觸的底線,軍法專刊,59期 2卷,頁124 ,2013年。\n20.臺灣醫界雜誌編輯部,醫界最終戰-不可不知的醫療糾紛處理及醫療事故補償辦法,中華民國醫師公會全國聯合會,第8 期,頁30-32,2015 年8 月。\n(三)網頁文獻\n1.周恬弘,醫療糾紛的結如何解?獨立評論@天下,2015 年5 月22 日,https://opinion.cw.com.tw/blog/profile/322/article/2853,最後瀏覽日:2019 年6 月1 日。\n2.周恬弘,坐下來,好好談——醫療糾紛可以不再兩敗俱傷,天下雜誌,2017年9 月5 日,https://opinion.udn.com/opinion/story/6785/2714099。最後瀏覽日:2019 年6 月1 日。\n3.鄭逸哲,「醫療常規」是虛構的概念,2012 年12 月19 日,https://www.facebook.com/doctorvoice.org/posts/148187385329412,最後瀏覽日:2019 年6 月1 日。\n4.醫療糾紛處理及醫療事故補償法草案初審通過,共創病人、醫療人員及法界三贏里程碑。衛福部醫事司,2014 年5 月13 日。http://www.mohw.gov.tw/cp-16-21988-1.html,最後瀏覽日:2019 年6 月1 日。\n5.用鍵盤摧毀一條人命:「網路霸凌現象與防制策略建構」,2018 年9月3日,https://www.thenewslens.com/article/101576,最後瀏覽日:2019 年6 月19日。\n(四)其他\n1.行政院衛生署公報,第 32 卷3 號,頁68-69。\n2.107-108年度醫院醫療品質及病人安全工作目標手冊。\n3.108年醫院評鑑基準及評量項目(區域醫院、地區醫院適用)。\n二、外文參考文獻\n1.Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy With Perioperative Outcomes and Health are Costs, 2003 to 015. JAMA. 2017;318(16):1561-1568.\n2.Bell GD, Charlton JE. Colonoscopy-Is sedation necessary and is there any role for intravenous propofol? Endoscopy 2000;32(3):264-7.\n3.Complications Following Colonoscopy with Anesthesia Assistance: A Population-Based Analysis. JAMA Intern Med. 2013 Apr 8; 173(7): 551–556.\n4.Froehlich F, Gonvers JJ, Fried M. Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland. Endoscopy 1994;26(2):231-4.\n5.Iber FL, Sutberry M, Gupta R, Kruss D. Evaluation of complications during and after conscious sedation for endoscopy using pulse oximetry. Gastrointestinal Endoscopy 1993;39(5):620-5.\n6.Jeanine P. Wiener-Kronish, and Michael A. Gropper. Conscious Sedation. Hanley & Belfus, Inc. 2001: 119-134\n7.Kulling D, Fantin AC, Biro P, Bauerfeind P, Fried M. Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil. Gastrointestinal Endoscopy 2001;54(1):1-7.\n8.Lazzaroni M, Porro GB. Preparation, premedication, and surveillance. Endoscopy 2001;33(2):103-8.\n9.Phillips MS. Drugs and sedation for colonoscopy. Primary Care; Clinics in Office Practice 1995;22(3):433-43.\n10.Roseveare C, Seavell C, Patel P, Criswell J, Shepherd H. Patient-controlled sedation with propofol and alfentanil during colonoscopy: a pilot study. Endoscopy 1998;30(5):482-3.\n11.The American Society of Anesthesiologists (ASA): Practice guidelines for sedation and analgesia by non-anesthesiologists. A report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologist. Anesthesiology 84:459-471, 1996.\n12.The American Society of Gastroenterology (ASGE): www.asge.org.\n13.The ROLARR Randomized Clinical Trial: Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer. JAMA. 2017;318(16):1569-1580\n14.Jemal A, Bray F , Center MM, et al. : Global cancer statistics. CA Cancer J Clin 2011;61:69-90.\n15.Edward BK, Ward E, Kohler BA, et al. : Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions(risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-573.\n16.Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests—United States, 2002 and 2004. MMWR Morb Mortal Wkly Rep 2008; 57:253-280.\n17.Centers for Disease Control and Prevention (CDC).Increased use of colorectal cancer tests—United States,2002 and 2004. MMWR Morb Mortal Wkly Rep 2006;55:308-311.\n18.Meissner HI, Breen N, Klabunde CN, et al.: Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15:389-394.\n19.Henley SJ, King JB, German RR, et al.: Surveillance of screening-detected cancers (colon and rectum, breast,and cervix) – United States, 2004-2006. MMWR Surveill Summ 2010; 59:1-25.\n20.Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.\n21.Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale.Gastroenterology 1997; 112:594-642.\n22.Soetikno RM, kaltenbach T, Rouse RV, et al.: Prevalence of nonpolypoid ( flat and depressed ) colorectal neoplasms in asymptomatic and symptomatic adults.JAMA 2008; 299:1027-1035.\n23.Chan AT, Giovannucci EL: Primary prevention of colorectal cancer. Gastroenterology 2010;138:2029-2043.\n24.Harvard Report on Cancer Prevention, Cancer Causes and Control 1999;10:167-180.\n25.Mandel JS, Church TR, Ederer F, et al.: Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-437.\n26.Ahlquist DA, Sargent DJ, Loprinzi CL, et al.: Stool DNA and fecal occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008; 149: 441-450.\n27.Atkins WS, Edwards R, Kralj-Hans I, et al.: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicenter randomized controlled trial. Lancet 2010; 375: 1624-1633.\n28.Levin B, Lieberman DA, McFarland B, et al.: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130-160.
描述: 碩士
國立政治大學
法學院碩士在職專班
100961013
資料來源: http://thesis.lib.nccu.edu.tw/record/#G0100961013
資料類型: thesis
Appears in Collections:學位論文

Files in This Item:
File SizeFormat
101301.pdf2.15 MBAdobe PDF2View/Open
Show full item record

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.